Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

By sjmartinez • April 2, 2025

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko A, Yothers G, Tighiouart M, Ganz PA. Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial. JNCI Cancer Spectr. 2025 Apr 1:pkaf032. doi: 10.1093/jncics/pkaf032. Epub ahead of print. PMID: 40170372.

Tags: Cedars Sinai DoM, General Internal Medicine, Hematology/Oncology, Publications

Topic Mapping to Inform Content to Discuss in Shared Decision-Making for Prostate Cancer

Friedrich NA, Kokorowski P, Luu M, Chaplin A, Polineni R, Shiang A, Shin D, Tan J, Freedland SJ, Spiegel B, Daskivich TJ. Topic Mapping to[...]

Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary Embolism

Watanabe A, Kuno T, Miyamoto Y, Ueyama HA, Gotanda H, Bangalore S, Tsugawa Y. Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary[...]

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective

Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK. Real-World[...]